Opens in a new tab
blog

Why machine translation post-editing can make or break your pharmaceutical document quality

30th September 2025
Author: Team Atlas

The pharmaceutical industry faces a constant challenge: how to manage vast volumes of documentation requiring translation while maintaining the exacting standards that regulatory compliance demands. Machine translation post-editing (MTPE) has emerged as a potential solution, but knowing when and how to implement it safely requires careful consideration.

Are you wondering what exactly MTPE is? Great question. Due to the recent-ish arrival of Artificial Intelligence (AI), you may have noticed some ‘weirdly worded’ content all over the internet. As we all know, fast doesn’t always mean good. This is becoming painfully apparent to many industries, including the translation and localisation sector. And that’s where MTPE comes in. It’s the process where professional translation agencies, like Atlas Translations, take material that has been poorly translated by AI. We then edit and correct it, ultimately elevating it to a professional and accurate standard 🧐

Several industries, including the pharmaceutical sector, have begun to adopt this two-stage approach. Industries are seeking a middle ground between option 1 (pure machine translation) to provide speed, and option 2 (full human translation) to provide accuracy. Obviously, the goal of this strategy is to potentially reduce costs and timelines while maintaining quality control.

Here at Atlas Translations, one point we’ve found is often overlooked is how pharmaceutical translation involves conveying meaning and preserving the precise technical language that regulatory bodies require. Additionally, even if reducing costs and timelines is the goal, it’s essential to make sure patient safety information remains clear across different languages.

Which approach works for different types pharmaceutical documentation?

Light editing candidates

Internal communications, preliminary research summaries, and early-stage documentation often work well with light MTPE. These documents typically require basic corrections for grammar, terminology consistency, and readability improvements.

Full post-editing scenarios

Technical product specifications, training materials, and non-regulatory clinical documents may benefit from more comprehensive MTPE. The machine translation provides a solid foundation, but human expertise makes sure of technical accuracy and language that is appropriate for regulatory purposes.

Documents needing human translation

Patient-facing materials, regulatory submissions, pharmacovigilance reports, and clinical trial protocols demand human translation from the outset. The stakes are simply too high for anything less than expert human judgement throughout the entire process.

Quality levels and risk assessment

We’ve observed that pharmaceutical companies need clear frameworks for deciding which approach suits different document types. The key factors include:

Regulatory impact

Documents destined for regulatory submission require the highest quality standards. Any ambiguity or error could delay approvals or raise compliance concerns.

Patient safety implications

Materials that directly or indirectly affect patient care—from prescribing information to clinical trial informed consent—need human expertise throughout the translation process.

Confidentiality requirements

Highly sensitive proprietary information may not be suitable for machine translation tools that store or learn from submitted content.

Timeline pressures

When speed is essential for non-critical documents, MTPE can provide faster turnaround than traditional translation and maintain acceptable quality standards.

The post-editor’s pharmaceutical expertise

Not all post-editors are created equal, particularly in pharmaceutical contexts. Effective pharmaceutical MTPE, like that found here at Atlas Translations, requires post-editors who understand:

  • Regulatory terminology across different markets
  • Clinical research protocols and methodologies
  • Pharmacovigilance reporting standards
  • Medical device classification systems
  • International harmonisation guidelines

This specialised knowledge helps post-editors to identify when machine translation has misunderstood context, used inappropriate terminology, or created potential safety ambiguities.

Maintaining audit trails and compliance

Pharmaceutical companies operate in highly regulated environments where audit trails are crucial. When implementing MTPE, we maintain detailed records of:

  • Which machine translation engines were used
  • The level of post-editing applied
  • Quality assurance checks performed
  • Final reviewer approvals

This documentation supports regulatory inspections and demonstrates due diligence in translation quality management.

Cost-benefit considerations

MTPE isn’t automatically cheaper than traditional translation. The cost-effectiveness depends on several factors:

Document volume: Large volumes of similar document types often benefit most from MTPE workflows.

Content complexity: Highly technical or nuanced content may require such extensive post-editing that traditional translation becomes more efficient.

Quality requirements: Documents requiring minimal revisions justify MTPE investment, but those needing substantial restructuring do not.

Revision cycles: If documents undergo multiple review rounds, starting with human translation often proves more efficient overall.

Making the right choice for your project

The decision between MTPE and traditional translation shouldn’t be based solely on cost considerations. We evaluate each project considering regulatory requirements, patient safety implications, timeline constraints, and quality expectations.

When you bring us the machine-translated content, we’ll evaluate what we can do with it to help. It could be some light editing if it’s just minor typos, words in the wrong place, or generally lacking personality.

On the other end of the spectrum, if it’s just an incredibly bad translation, we may say that machine translation post-editing isn’t your best option, and you may as well get it translated from scratch.

Building internal MTPE capabilities

Some pharmaceutical companies consider developing internal MTPE capabilities, particularly for high-volume, routine documentation. This approach can be effective, provided companies have dedicated translation staff with pharmaceutical expertise and can invest in the necessary technology infrastructure.

However, most companies find that partnering with specialised translation agencies provides better results and avoids the overhead of maintaining internal MTPE systems. Training staff on evolving technology and ensuring consistent quality across different document types and language pairs is also key.

It’s a wrap!

MTPE represents a valuable tool in the pharmaceutical translation toolkit when applied thoughtfully. The key lies in understanding which documents suit which approach, ensuring your translation partner has the pharmaceutical expertise necessary for effective post-editing, and maintaining the quality standards that regulatory compliance demands.

Rather than viewing MTPE as a universal cost-cutting measure, a successful pharmaceutical company will treat it as one component of a comprehensive translation strategy.

Atlas Translations knows that optimising resources is important to any organisation. However, we also know that prioritising patient safety and regulatory compliance is not an area to cut corners.

Wondering if MTPE will work for your pharma project?

Send us what you've got and we'll recommend which way to go.

Call us on 01727 812 725

Tell us some details and get a quote

Use the chatbox to start a conversation. It’s a real-life human, no bots here! (During UK business hours – we do need to sleep.)

See more options on our contact page.

Further reading

10th March 2026

What happens when a translation goes wrong? (and how to make sure it doesn’t)

Read post
9th September 2025

Medical device translation: ensuring patient safety across global markets

Read post
18th February 2025

5 key benefits of working with a certified translation service

Read post
All blog posts